期刊文献+

碘摄入量与甲状腺乳头状癌关系的Meta分析

Meta analysis of the relationship between iodine intake and papillary thyroid carcinoma
下载PDF
导出
摘要 目的探究碘摄入量与甲状腺乳头状癌(PTC)的相关性。方法根据PICOS制定检索策略,收集Pubmed、Cochrane Library、Web of Science、CNKI和万方数据库中有关碘摄入量与PTC的病例对照研究共12篇参考文献,共计纳入6214名研究对象,进行Meta分析。结果碘摄入水平过量与PTC的发生有关(OR=5.66,95%CI:2.25~12.68,P<0.001),而适量的碘摄入则能够降低PTC的发生风险(OR=0.26,95%CI:0.13~0.52,P<0.01)。碘摄入水平过量与PTC包膜外侵犯(ENE)、中央区淋巴结转移(CLNM)、BRAF基因突变等无关。结论碘摄入过量增加PTC发生风险,适量的碘摄入是PTC的保护因素。 Objective This study aimed to explore the correlation between iodine intake and papillary thyroid carcinoma(PTC).Methods After formulating a search strategy based on PICOS,12 case-control studies on iodine intake and PTC were collected from PubMed,Cochrane Library,Web of Science,CNKI,and Wanfang databases,including a total of 6214 research subjects,and Meta-analysis was performed.Results The Meta-analysis indicated that there was a positive correlation between excessive iodine intake and the incidence of PTC(OR=5.66,95%CI:2.25~12.68,P<0.05),while moderate iodine intake could reduce the risk of PTC(OR=0.26,95%CI:0.13~0.52,P<0.01).Excessive iodine intake may not be related to such factors as extrathyroidal extension(ENE),the central lymph node metastasis(CLNM),and BRAF gene mutations.Conclusions Excessive iodine intake increases the risk of PTC,and moderate iodine intake may be a protective factor for PTC.
作者 尉志伟 徐斐 王廷 YU Zhiwei;XU Fei;WANG Ting(Department of Thyroid,Breast and Vascular Surgery,Xijing Hospital,Fourth Military Medical University,Xi'an 710032,China)
出处 《中国肿瘤外科杂志》 CAS 2024年第3期253-260,共8页 Chinese Journal of Surgical Oncology
基金 陕西省卫生健康科研基金扶植项目(2018D070)。
关键词 甲状腺乳头状癌 碘摄入量 碘营养 尿碘 META分析 Papillary thyroid carcinoma Iodine Iodine intake Iodine nutrition Urinary iodine Meta-analysis
  • 相关文献

参考文献4

二级参考文献34

  • 1钱碧云,陈可欣,何敏,董淑芬,韩宏伟,雷蕾,王继芳.天津市区甲状腺癌流行状况调查[J].中国肿瘤临床,2005,32(4):218-221. 被引量:56
  • 2范义兵,陈海婴,凌军,王菁.尿碘作为碘缺乏病监测指标的意义[J].中国地方病学杂志,2005,24(3):346-348. 被引量:184
  • 3Laurberg P,Bülow Pedersen I,Knudsen N,et al.Environmental iodine intake affects the type of nonmalignant thyroid disease[J].Thyroid,2001,11(5):457-469.
  • 4Onaran Y.Tezelman S,Gurel N.et al.The value of DNA content in predicting the prognosis of thyroid carcinoma in an endemic iodine deficiency region[J].Acta Chit Belg,1999,99(1):30-35.
  • 5Dal Maso L,Bosetti G,La Vecchia C,et al.Risk factors for thyroid Cancer:an epidemiological review focused on nutritional factors[J].Cancer Gauses Gontrol,2009,20(1):75-86.
  • 6Sehestedt T.Knudsen N,Perrild H,et al.Iodine intake and dincidence of thyroid cancer in Denmark[J].Clin Endocrinol(Oxf),2006,65(2):229-233.
  • 7Knobel M,Medeiros-Nao G.Relevance of iodine intake as a reputed predisposing factor for thyroid cancer[J].Arq Bras Endocrinol Metabol,2007,51(5):701-712.
  • 8Yamashita H,Noguchi S,Murakami N,et al.Effects of dietary iodine on chemical induction of thyroid carcinoma[J].Acta Pathol Jpn,1990,40(10):705-712.
  • 9Guan H,Ji M,Bao R,et al.Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer[J].J Clin Endocrinol Metab,2009,94(5):1612-1617.
  • 10Lee X,Gao M,Ji Y,et al.Analysis of differential BRAF(V600E) mutadonal status in high aggressive papillary thyroid microcardnoma[J].Ann Surg Oncol,2009,16(2):240-245.

共引文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部